Literature DB >> 9673547

Serum interleukin-6, interleukin-8, hepatocyte growth factor, and nitric oxide changes during thoracic surgery.

T Yamada1, M Hisanaga, Y Nakajima, H Kanehiro, A Watanabe, T Ohyama, K Nishio, M Sho, M Nagao, A Harada, K Matsushima, H Nakano.   

Abstract

Thoracic surgery creates a different environment from abdominal surgery in respect to the surgical procedure with pulmonary collapse under unilateral ventilation. Definitive evidence whether surgical trauma during thoracotomy is involved in postoperative pulmonary infections has not been clearly demonstrated. The objectives of this study were to evaluate the influence of surgical trauma during thoracotomy on postoperative infections and to investigate the clinical significance of postoperative humoral mediators in pulmonary infections after surgery. We measured serum interleukin-6 (IL-6), IL-8, hepatocyte growth factor (HGF), and nitric oxide (NO) levels in 27 patients undergoing thoracic surgery; the measurements were before and during thoracotomy, 60 minutes after reinflation, and after surgery. The patients were divided into three groups: lobectomy patients (group A), and esophagectomy patients without (group B) or with (group C) postoperative infections. The serum IL-6 and IL-8 levels in group C were markedly elevated 60 minutes after reinflation and were significantly higher than those in group A. The serum IL-8 levels during that period in group C were significantly higher than those in group B. The postoperative serum IL-6, IL-8, HGF, and NO levels were significantly higher in group c than in group B. Taken together, intraoperative hypercytokinemia, especially IL-8, following the thoracic procedure and subsequent reinflation preceded the clinical onset of postoperative infections. Hence postoperative serum IL-6, IL-8, and HGF levels may be useful predictors of infection after esophagectomy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673547     DOI: 10.1007/s002689900470

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

1.  Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefit.

Authors:  Hartmut Koeppen; Wei Yu; Jiping Zha; Ajay Pandita; Elicia Penuel; Linda Rangell; Rajiv Raja; Sankar Mohan; Rajesh Patel; Rupal Desai; Ling Fu; An Do; Vaishali Parab; Xiaoling Xia; Tom Januario; Sharianne G Louie; Ellen Filvaroff; David S Shames; Ignacio Wistuba; Marina Lipkind; Jenny Huang; Mirella Lazarov; Vanitha Ramakrishnan; Lukas Amler; See-Chun Phan; Premal Patel; Amy Peterson; Robert L Yauch
Journal:  Clin Cancer Res       Date:  2014-03-31       Impact factor: 12.531

2.  Cytokine Response in the Pleural Fluid and Blood in Minimally Invasive and Open Esophagectomy.

Authors:  T Delko; D I Watson; B Beck-Schimmer; A Immanuel; D J Hussey; U Zingg
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

3.  Nitrite/nitrate oxide and cytokines changes in patients with surgical stress.

Authors:  Naoki Hirabayashi; Hiroshi Tanimura; Hiroki Yamaue
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

4.  Prospective, randomized comparison of epidural versus parenteral opioid analgesia in thoracic trauma.

Authors:  M R Moon; F A Luchette; S W Gibson; J Crews; G Sudarshan; J M Hurst; K Davis; J A Johannigman; S B Frame; J E Fischer
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

5.  Postmortem cytokine levels and severity of traumatic injuries.

Authors:  Sohtaro Mimasaka; Yuki Ohtsu; Shigeyuki Tsunenari; Masato Funayama
Journal:  Int J Legal Med       Date:  2006-04-04       Impact factor: 2.686

Review 6.  The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer.

Authors:  Kim Moran-Jones
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

Review 7.  Acute respiratory distress syndrome after pulmonary resection.

Authors:  Takuro Kometani; Tatsuro Okamoto; Shigetoshi Yoshida; Ichiro Yoshino
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-06-18

8.  Immunological changes after minimally invasive or conventional esophageal resection for cancer: a randomized trial.

Authors:  K W Maas; S S A Y Biere; I M W van Hoogstraten; D L van der Peet; M A Cuesta
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

9.  Low invasiveness of thoracoscopic esophagectomy in the prone position for esophageal cancer: a propensity score-matched comparison of operative approaches between thoracoscopic and open esophagectomy.

Authors:  Shinsuke Kanekiyo; Shigeru Takeda; Masahito Tsutsui; Mitsuo Nishiyama; Masahiro Kitahara; Yoshitaro Shindo; Yukio Tokumitsu; Shinobu Tomochika; Yoshihiro Tokuhisa; Michihisa Iida; Kazuhiko Sakamoto; Nobuaki Suzuki; Shigeru Yamamoto; Shigefumi Yoshino; Shoichi Hazama; Tomio Ueno; Hiroaki Nagano
Journal:  Surg Endosc       Date:  2017-10-26       Impact factor: 4.584

10.  Immunological Evaluation of Surgical Stress in Liver Resections.

Authors:  Alexandru Munteanu; Gabriel Samasca; Iulia Lupan; Cornel Iancu
Journal:  Maedica (Bucur)       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.